Inhibition of angiogenesis by IL-32: Possible role in asthma

Background IL-32 is a proinflammatory cytokine involved in various chronic inflammatory diseases. Chronic airway inflammation in asthmatic patients results in structural airway changes, including angiogenesis. Vascular endothelial growth factor (VEGF) is a key inducer of angiogenesis in the airways...

Full description

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 129; no. 4; pp. 964 - 973.e7
Main Authors Meyer, Norbert, MD, Christoph, Janine, MSc, Makrinioti, Heidi, MD, Indermitte, Philippe, Dipl Ing FH, Rhyner, Claudio, PhD, Soyka, Michael, MD, Eiwegger, Thomas, MD, Chalubinski, Maciej, MD, PhD, Wanke, Kerstin, MSc, Fujita, Hiroyuki, MD, PhD, Wawrzyniak, Paulina, MSc, Bürgler, Simone, PhD, Zhang, Sherrie, PhD, Akdis, Mübeccel, MD, PhD, Menz, Günter, MD, Akdis, Cezmi, MD
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.04.2012
Elsevier
Elsevier Limited
Subjects
HIV
ECP
TLR
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background IL-32 is a proinflammatory cytokine involved in various chronic inflammatory diseases. Chronic airway inflammation in asthmatic patients results in structural airway changes, including angiogenesis. Vascular endothelial growth factor (VEGF) is a key inducer of angiogenesis in the airways of asthmatic patients. Objective The aim of the study was to investigate the expression and function of IL-32 in patients with angiogenesis and asthma. Methods The expression and regulation of IL-32 in normal human bronchial epithelial (NHBE) cells was analyzed by using RT-PCR, ELISA, Western blotting, immunofluorescent staining, and flow cytometry. After knockdown of IL-32 in NHBE cells by small interfering RNA (siRNA) transfections, VEGF secretion was quantified by means of ELISA. New blood vessel formation was determined with human umbilical vein endothelial cells by culturing with supernatants from IL-32 siRNA–transfected NHBE cells. IL-32 was determined in serum and induced sputum samples of asthmatic patients and healthy control subjects by means of ELISA. Results IL-32 is expressed in NHBE cells on stimulation with IFN-γ, TNF-α, TH 1 cells, and rhinovirus. Inhibition of IL-32 expression resulted in significantly increased secretion of the proangiogenic factors VEGF and platelet-derived growth factor by NHBE cells. Human umbilical vein endothelial cells cultured in supernatants from IL-32 siRNA–transfected NHBE cells showed enhanced in vitro angiogenesis. IL-32 is detectable in induced sputum from asthmatic patients. IL-32 serum levels were significantly higher in asthmatic patients compared with those seen in healthy control subjects and correlated with response to asthma treatment. Conclusion IL-32 is induced by IFN-γ, TNF-α, TH 1 cells, and rhinovirus in bronchial epithelial cells. It inhibits angiogenesis, and its serum levels are associated with a good treatment response in asthmatic patients.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2011.12.1002